Clone:
REAL1137
Type of antibody:
Releasable fluorochromes, Primary antibodies, Recombinant antibodies
Applications:
MICS, IHC, IF
Alternative names:
Arginase 1, Liver-type arginase, ARG1

Specifications for Arginase-1 Antibody, anti-human, REAdye_lease™

Overview

Clone REAL1137 is an antibody fragment derived from the full Arginase-1 antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity.
Clone REAL1137 recognizes the isoenzyme Arginase-1, also known as ARG1, which is a member of the ureohydrolase family of enzymes. Arginase-1 converts L-arginine into L-ornithine and urea, which is then converted to polyamine. This process takes place primarily in the liver and, to a lesser extent, in the kidneys. Arginase -1 is also expressed in granulocytes, neural stem cells, and in myeloid derived suppressor cells (MDSC) and plays a role in the antimicrobial effector pathway in polymorphonuclear granulocytes. Mutations, which cause Arginase deficiency, can lead to defects in the urea cycle with hyperammonaemia. Arginase-1 is reported to be expressed in colorectal cancer and is found in the majority of hepatocellular carcinomas.
For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675).

Alternative names

Arginase 1, Liver-type arginase, ARG1

Detailed product information

Technical specifications

CloneREAL1137
Clonalitymonoclonal
Isotype controlControl Antibody
Hostcell line
Type of antibodyReleasable fluorochromes, Primary antibodies, Recombinant antibodies
Specieshuman
AntigenArginase-1
Alternative names of antigenArginase 1, Liver-type arginase, ARG1
Distribution of antigengranulocytes, myeloid-derived suppressor cells, tumor cells, neural stem cells, liver, kidney

References for Arginase-1 Antibody, anti-human, REAdye_lease™

Publications

  1. Wu, G. et al. (1998) Arginine metabolism: nitric oxide and beyond. Biochem. J. 336(Pt 1): 1-17
  2. Oberlies, J. et al. (2009) Regulation of NK cell function by human granulocyte arginase. J. Immunol. 182(9): 5259-5267
  3. You, J. et al. (2018) The Oncogenic Role of ARG1 in Progression and Metastasis of Hepatocellular Carcinoma. Biomed Res Int : 2109865
  4. Ma, Z. et al. (2019) Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer. Pathol. Res. Pract. 215(6): 152383

Seems like you are coming from USA!
Do you want to visit our website in your country?